Ing-cc-0073

Author: mjkq

August undefined, 2024

Webb5/1/2024 ING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy Revised 5/1/2024 ING-CC-0075 Rituxan (rituximab) for Non-Oncologic Indications Revised . Page 3 of 3 Effective …

Updated Minnesota Health Care Programs and Minnesota Senior …

Webb56 rader · 1 dec. 2024 · Mar 1, 2024 • Products & Programs / Pharmacy. On December 1, 2024, Anthem Blue Cross and Blue Shield (Anthem) introduced the new clinical criteria … WebbCC-0025 Aldurazyme (laronidase) CC -0073 Alpha 1 Proteinase Inhibitor Therapy CC-0189 Amondys 45 (casimersen) CC-0217 Amvuttra (vutrisiran) CC-0083 Aristada Initio (aripiprazole lauroxil) CC-0122 Arzerra (ofatumumab) CC-0096 Asparagine Specific Enzymes (Oncaspar (pegaspargase), Rylaze (asparaginase erwinia chrysanthemi small square inflatable pool

Medical drug benefit Clinical Criteria updates

WebbMarch 26, 2024 ING-CC-0073* Alpha-1 Proteinase Inhibitor Therapy Revised March 26, 2024 ING-CC-0075 Rituximab Agents for Non-Oncologic Indications Revised March 26, 2024 ING-CC-0072 Selective Vascular Endothelial Growth Factor (VEGF) Antagonists Revised March 26, 2024 ING-CC-0027* Denosumab Agents Revised March 26, 2024 … WebbING-CC-0053 Injectable Hydroxyprogesterone for Prevention of Preterm Birth Revised March 17, 2024 ING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy Revised March 17, 2024 ING-CC-0049 Radicava (edaravone) Revised March 17, 2024 ING-CC-0040 Prialt (ziconotide) Revised March 17, 2024 ING-CC-0079 Strensiq (asfotase alfa) Revised … Webb1 juli 2024 · Effective August 1, 2024, we may request additional documentation for impacted medications to determine medical necessity. Upon request, providers shall … highway 9 forms

July 2024 Anthem Provider News - Missouri

WebbING-CC-0073 . J0256 Aralast ING-CC-0073 : J0257 Glassia ING-CC-0076 . J0485 Nulojix ING-CC-0028 : J0490 Benlysta ING-CC-0043 . J0517 Fasenra ING-CC-0046 : J0565 … WebbThis page provides the clinical criteria documents for all injectable, infused, or implanted prescription drugs and therapies covered under the medical benefit. The effective dates … highway 9 drumheller depotWebbING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy Revised 5/1/2024 ING-CC-0075 Rituxan (rituximab) for Non-Oncologic Indications Revised 5/1/2024 J1442, J1447, … small square kitchen table with 4 chairs

"WebbING-CC-0043* Monoclonal Antibodies to Interleukin-5 Revised 03/30/2024 ING-CC-0055 Fuzeon (enfuvirtide) Revised 03/30/2024 ING-CC-0047 Trogarzo (ibalizumab-uiyk) … " - Ing-cc-0073

Ing-cc-0073

WebbFebruary 19, 2024 ING-CC-0142 Somatuline Depot (lanreotide)* New February 19, 2024 ING-CC-0143 Polivy (polatuzumab vedotin-piiq)* New ... February 19, 2024 ING-CC-0073 Alpha-1 Proteinase Inhibitor Revised . Healthy Blue Medicaid Managed Care Medical drug benefit Clinical Criteria updates Page 2 of 2 WebbCC-0025 Aldurazyme (laronidase) CC -0073 Alpha 1 Proteinase Inhibitor Therapy CC-0189 Amondys 45 (casimersen) CC-0217 Amvuttra (vutrisiran) CC-0083 Aristada Initio …

Did you know?

WebbING-CC-0073 ; Publish Date: 01/01/202409/23/2024 . Status: Revised . Last Review Date: 11/16/2024 . Table of Contents . Overview Coding References Clinical criteria … WebbCentral ING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy Drugs 3/1/2024 Central ING-CC-0074 Akynzeo (fosnetupitant and palonosetron) for Injection Drugs 5/1/2024 NOTE: …

Webb1 juni 2024 · ING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy ING-CC-0077 Palynziq (pegvaliase-pqpz) ING-CC-0079 Strensiq (asfotase alfa) ING-CC-0081 Crysvita (burosumab-twza) ING-CC-0082 Onpattro (patisiran) ING-CC-0148 Agents for Hemophilia B ING-CC-0152 Vyondys 53 (golodirsen) ING-CC-0156 Reblozyl (luspatercept) ING-CC … WebbJuly 28, 2024 ING-CC-0075* Rituximab Agents for Non-Oncologic Indications Revised BNE-NL-0053-21. Page 6 of 7 ... ING-CC-0073: Alpha-1 Proteinase Inhibitor Therapy Aralast, Glassia, Prolastin-C, Zemaira ING-CC-0028: Benlysta (belimumab) Benlysta ING-CC-0012: Brineura (cerliponase alfa)

WebbFebruary 19, 2024 ING-CC-0142 Somatuline Depot (lanreotide)* New February 19, 2024 ING-CC-0143 Polivy (polatuzumab vedotin-piiq)* New ... February 19, 2024 ING-CC … WebbING-CC-0074 Akynzeo (fosnetupitant and palonosetron) for Injection New 3/18/2024 ING-CC-0077 Palynziq (pegvaliase-pqpz) New ... 3/18/2024 ING-CC-0073 Alpha-1 …

WebbING-CC-0121 Gazyva (obinutuzumab) Yes Yes ING-CC-0002 Colony Stimulating Factor Agents Yes Yes ING-CC-0003 Immunoglobulins Yes Yes ING-CC-0039 GamaSTAN …

WebbAugust 30, 2024 ING-CC-0073* Alpha-1 Proteinase Inhibitor Therapy Revised August 30, 2024 ING-CC-0075* Rituximab Agents for Non-Oncologic Indications Revised August … highway 9 edmonton albertaWebb06/07/2024 ING-CC-0177* Zilretta (triamcinolone acetonide extended-release) New . Healthy Blue Medicaid Managed Care Medical drug benefit Clinical Criteria updates ... 06/07/2024 ING-CC-0073* Alpha-1 Proteinase Inhibitor Therapy Revised 06/07/2024 ING-CC-0082* Onpattro (patisiran) Revised 06/07/2024 ING-CC-0084* Tegsedi (inotersen) ... highway 9 equipment repairWebbPage 2 of 3 Effective date Document number Clinical Criteria title New, revised, annual review December 11, 2024 ING-CC-0129 Bavencio (avelumab) Revised December 11, 2024 ING-CC-0130 Imfinzi (durvalumab) Revised December 11, 2024 ING-CC-0119 Yervoy (ipilimumab) Revised December 11, 2024 ING-CC-0094 Alimta (pemetrexed … highway 9 freightWebb23 sep. 2024 · ING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy ING-CC-0075 Rituximab Agents for Non-Oncology Indications ING-CC-0082 Onpattro (patisiran) ING-CC-0106 Erbitux (cetuximab) ING-CC-0107 Bevacizumab for Non-Ophthalmologic Indications New Clinical Criteria effective February 1, 2024 The following clinical criteria … small square neck scarves for womenWebbCC-0073: J0256, J0257: Aristada Initio (aripiprazole lauroxil) CC-0083: J1943: Arzerra (ofatumumab) CC-0122 J9302 ... CC-0219: J0879 Briumvi (ublituximab) CC-0227: … Advantage Network (Includes Retail 90 and Rx Maintenance 90) Available as … The Food and Drug Administration (FDA) is restricting the use of Ocaliva® … Site Map - Clinical Criteria - Anthem HoN Code - Clinical Criteria - Anthem Privacy - Clinical Criteria - Anthem About Us - Clinical Criteria - Anthem highway 9 fatal accidentWebbPage 2 of 3 Effective date Document number Clinical Criteria title New, revised, annual review November 30, 2024 ING -CC-0125 Opdivo (nivolumab) Revised November 30, 2024 ING -CC-0129 Bavencio (avelumab) Revised November 30, 2024 ING -CC-0130 Imfinzi (durvalumab) Revised November 30, 2024 ING -CC-0119 Yervoy (ipilimumab) … highway 9 fatal accident caWebbING-CC-0065 Agents for Hemophilia A and von Willebrand Disease Yes Yes ING-CC-0002 Colony Stimulating Factor ... ING-CC-0073 Alpha-1 Proteinase Inhibitor Therapy Yes Yes ING-CC-0040 Prialt (ziconotide) Yes Yes ING-CC-0075 Rituximab Agents for Non-Oncologic Indications Yes Yes ING-CC-0072 Selective Vascular Endothelial Growth ... small square ottoman charcoal leather